Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1909 to 1919 of 1919 entries
Sorted by: Best Match Show Resources per page
Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Quartieri E, Marraccini C, Merolle L, Pulcini S, Buzzi M, Guardi M, Schiroli D, Baricchi R, Pertinhez TA.
PMID: 33975808
Transfus Apher Sci. 2021 Aug;60(4):103155. doi: 10.1016/j.transci.2021.103155. Epub 2021 May 08.

Allogeneic peripheral blood-derived (PBS) serum eye drops have been largely used in the treatment of dry eye disease (DED). Recently, cord blood has emerged as an effective alternative serum source (cord blood serum, CBS), containing a higher amount of...

Cite
Quartieri E, Marraccini C, Merolle L, et al. Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease. Transfus Apher Sci. 2021;60(4):103155doi: 10.1016/j.transci.2021.103155.
Quartieri, E., Marraccini, C., Merolle, L., Pulcini, S., Buzzi, M., Guardi, M., Schiroli, D., Baricchi, R., & Pertinhez, T. A. (2021). Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 60(4), 103155. https://doi.org/10.1016/j.transci.2021.103155
Quartieri, Eleonora, et al. "Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease." Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis vol. 60,4 (2021): 103155. doi: https://doi.org/10.1016/j.transci.2021.103155
Quartieri E, Marraccini C, Merolle L, Pulcini S, Buzzi M, Guardi M, Schiroli D, Baricchi R, Pertinhez TA. Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease. Transfus Apher Sci. 2021 Aug;60(4):103155. doi: 10.1016/j.transci.2021.103155. Epub 2021 May 08. PMID: 33975808.
Copy Download .nbib Format: NLM
Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma.

Clinical genitourinary cancer

Jain RK, Skelton Iv WP, Pond GR, Naqvi M, Kim Y, Curran C, Freeman D, Nuzzo PV, Alaiwi SA, Nassar AH, Jain RK, Sonpavde G.
PMID: 34011489
Clin Genitourin Cancer. 2021 Dec;19(6):540-546. doi: 10.1016/j.clgc.2021.04.002. Epub 2021 Apr 20.

BACKGROUND: The renin-angiotensin system is involved in the regulation of angiogenesis and cell proliferation. Angiotensin inhibition may improve drug delivery by enhancing tumor perfusion partly by downregulating transforming growth factor (TGF)-β. Because TGF-β is associated with resistance in patients...

Cite
Jain RK, Skelton Iv WP, Pond GR, et al. Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma. Clin Genitourin Cancer. 2021;19(6):540-546doi: 10.1016/j.clgc.2021.04.002.
Jain, R. K., Skelton Iv, W. P., Pond, G. R., Naqvi, M., Kim, Y., Curran, C., Freeman, D., Nuzzo, P. V., Alaiwi, S. A., Nassar, A. H., Jain, R. K., & Sonpavde, G. (2021). Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma. Clinical genitourinary cancer, 19(6), 540-546. https://doi.org/10.1016/j.clgc.2021.04.002
Jain, Rohit K, et al. "Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma." Clinical genitourinary cancer vol. 19,6 (2021): 540-546. doi: https://doi.org/10.1016/j.clgc.2021.04.002
Jain RK, Skelton Iv WP, Pond GR, Naqvi M, Kim Y, Curran C, Freeman D, Nuzzo PV, Alaiwi SA, Nassar AH, Jain RK, Sonpavde G. Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma. Clin Genitourin Cancer. 2021 Dec;19(6):540-546. doi: 10.1016/j.clgc.2021.04.002. Epub 2021 Apr 20. PMID: 34011489; PMCID: PMC8526625.
Copy Download .nbib Format: NLM
Comparison of Performances of Infliximab Biosimilars CT-P13 Versus SB2 in the Treatment of Inflammatory Bowel Diseases: A Real-Life Multicenter, Observational Study in Italy.

Expert opinion on biological therapy

Tursi A, Mocci G, Allegretta L, Aragona G, Bianco MA, Colucci R, Cuomo A, Della Valle N, Ferronato A, Forti G, Gaiani F, Graziani MG, Lorenzetti R, Luzza F, Paese P, Penna A, Pica R, Pranzo G, Rodinò S, Scarcelli A, Zampaletta C, Brozzi L, Cicerone C, Cocco A, De' Angelis G, Donnarumma L, Fiorella S, Iannelli C, Larussa T, Le Grazie M, Luppino I, Meucci C, FaggianI R, Pagnini C, Perazzo P, Rodriguez-Castro KI, Sacco R, Sebkova L, Serio M, De Monti A, Picchio M, Napolitano D, Schiavoni E, Turchini L, Scaldaferri F, Pugliese D, Guidi L, Laterza L, Privitera G, Pizzoferrato M, Lopetuso LR, Armuzzi A, Elisei W, Maconi G, Papa A.
PMID: 34904510
Expert Opin Biol Ther. 2021 Dec 14; doi: 10.1080/14712598.2022.2007881. Epub 2021 Dec 14.

BACKGROUND: To compare the performances of Infliximab (IFX) biosimilar CT-P13 and SB2 in the treatment of Inflammatory Bowel Diseases (IBD) outpatients in Italy.RESEARCH DESIGN AND METHODS: 380 IBD outpatients were retrospectively evaluated. The primary endpoint was to compare the...

Cite
Tursi A, Mocci G, Allegretta L, et al. Comparison of Performances of Infliximab Biosimilars CT-P13 Versus SB2 in the Treatment of Inflammatory Bowel Diseases: A Real-Life Multicenter, Observational Study in Italy. Expert Opin Biol Ther. 2021;doi: 10.1080/14712598.2022.2007881.
Tursi, A., Mocci, G., Allegretta, L., Aragona, G., Bianco, M. A., Colucci, R., Cuomo, A., Della Valle, N., Ferronato, A., Forti, G., Gaiani, F., Graziani, M. G., Lorenzetti, R., Luzza, F., Paese, P., Penna, A., Pica, R., Pranzo, G., Rodinò, S., Scarcelli, A., Zampaletta, C., Brozzi, L., Cicerone, C., Cocco, A., De' Angelis, G., Donnarumma, L., Fiorella, S., Iannelli, C., Larussa, T., Le Grazie, M., Luppino, I., Meucci, C., FaggianI, R., Pagnini, C., Perazzo, P., Rodriguez-Castro, K. I., Sacco, R., Sebkova, L., Serio, M., De Monti, A., Picchio, M., Napolitano, D., Schiavoni, E., Turchini, L., Scaldaferri, F., Pugliese, D., Guidi, L., Laterza, L., Privitera, G., Pizzoferrato, M., Lopetuso, L. R., Armuzzi, A., Elisei, W., Maconi, G., & Papa, A. (2021). Comparison of Performances of Infliximab Biosimilars CT-P13 Versus SB2 in the Treatment of Inflammatory Bowel Diseases: A Real-Life Multicenter, Observational Study in Italy. Expert opinion on biological therapy, . https://doi.org/10.1080/14712598.2022.2007881
Tursi, Antonio, et al. "Comparison of Performances of Infliximab Biosimilars CT-P13 Versus SB2 in the Treatment of Inflammatory Bowel Diseases: A Real-Life Multicenter, Observational Study in Italy." Expert opinion on biological therapy vol. (2021). doi: https://doi.org/10.1080/14712598.2022.2007881
Tursi A, Mocci G, Allegretta L, Aragona G, Bianco MA, Colucci R, Cuomo A, Della Valle N, Ferronato A, Forti G, Gaiani F, Graziani MG, Lorenzetti R, Luzza F, Paese P, Penna A, Pica R, Pranzo G, Rodinò S, Scarcelli A, Zampaletta C, Brozzi L, Cicerone C, Cocco A, De' Angelis G, Donnarumma L, Fiorella S, Iannelli C, Larussa T, Le Grazie M, Luppino I, Meucci C, FaggianI R, Pagnini C, Perazzo P, Rodriguez-Castro KI, Sacco R, Sebkova L, Serio M, De Monti A, Picchio M, Napolitano D, Schiavoni E, Turchini L, Scaldaferri F, Pugliese D, Guidi L, Laterza L, Privitera G, Pizzoferrato M, Lopetuso LR, Armuzzi A, Elisei W, Maconi G, Papa A. Comparison of Performances of Infliximab Biosimilars CT-P13 Versus SB2 in the Treatment of Inflammatory Bowel Diseases: A Real-Life Multicenter, Observational Study in Italy. Expert Opin Biol Ther. 2021 Dec 14; doi: 10.1080/14712598.2022.2007881. Epub 2021 Dec 14. PMID: 34904510.
Copy Download .nbib Format: NLM
Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction.

International journal of molecular sciences

Lagos KJ, Buzzá HH, Bagnato VS, Romero MP.
PMID: 35008458
Int J Mol Sci. 2021 Dec 21;23(1). doi: 10.3390/ijms23010022.

Within phototherapy, a grand challenge in clinical cancer treatments is to develop a simple, cost-effective, and biocompatible approach to treat this disease using ultra-low doses of light. Carbon-based materials (CBM), such as graphene oxide (GO), reduced GO (r-GO), graphene...

Cite
Lagos KJ, Buzzá HH, Bagnato VS, et al. Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010022.
Lagos, K. J., Buzzá, H. H., Bagnato, V. S., & Romero, M. P. (2021). Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010022
Lagos, Karina J, et al. "Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010022
Lagos KJ, Buzzá HH, Bagnato VS, Romero MP. Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction. Int J Mol Sci. 2021 Dec 21;23(1). doi: 10.3390/ijms23010022. PMID: 35008458.
Copy Download .nbib Format: NLM
Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses.

Urologic oncology

Srivastava A, Uzzo RN, Lee J, Cho E, Grieco A, Masic S, Handorf E, Chen DYT, Viterbo R, Greenberg RE, Smaldone MC, Kutikov A, Uzzo RG.
PMID: 34301455
Urol Oncol. 2021 Nov;39(11):790.e9-790.e15. doi: 10.1016/j.urolonc.2021.06.015. Epub 2021 Jul 21.

INTRODUCTION AND OBJECTIVES: Renal mass biopsy (RMB) has not been widely adopted in evaluating small renal mass due to concerns for safety, efficacy, and its perceived lack of consequence on management decisions. We assess the potential cost savings and...

Cite
Srivastava A, Uzzo RN, Lee J, et al. Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses. Urol Oncol. 2021;39(11):790.e9-790.e15doi: 10.1016/j.urolonc.2021.06.015.
Srivastava, A., Uzzo, R. N., Lee, J., Cho, E., Grieco, A., Masic, S., Handorf, E., Chen, D. Y. T., Viterbo, R., Greenberg, R. E., Smaldone, M. C., Kutikov, A., & Uzzo, R. G. (2021). Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses. Urologic oncology, 39(11), 790.e9-790.e15. https://doi.org/10.1016/j.urolonc.2021.06.015
Srivastava, Abhishek, et al. "Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses." Urologic oncology vol. 39,11 (2021): 790.e9-790.e15. doi: https://doi.org/10.1016/j.urolonc.2021.06.015
Srivastava A, Uzzo RN, Lee J, Cho E, Grieco A, Masic S, Handorf E, Chen DYT, Viterbo R, Greenberg RE, Smaldone MC, Kutikov A, Uzzo RG. Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses. Urol Oncol. 2021 Nov;39(11):790.e9-790.e15. doi: 10.1016/j.urolonc.2021.06.015. Epub 2021 Jul 21. PMID: 34301455.
Copy Download .nbib Format: NLM
It is possible to create a vascular access team in a middle resource country? Experience of Hevi Paediatric Teaching Hospital at DUHOK - IRAQ.

The journal of vascular access

Federica B, Nizar Yahya B, Hevan Al-Atroushy A, Wahida Ibraheem A, Bayar Saleem H, Bijeen Fareq J, Sholker Khalid M, Shaima Shimo J, Nora Suleeman S, Saad Zebari M, Stefano M.
PMID: 34903090
J Vasc Access. 2021 Dec 13;11297298211055402. doi: 10.1177/11297298211055402. Epub 2021 Dec 13.

BACKGROUND: Vascular access devices are critically important for the treatment of neonates and paediatric patients. Vascular cannulation is a key clinical skill for healthcare professionals working in the neonatal and paediatric wards. The creation of specialised Teams dedicated to...

Cite
Federica B, Nizar Yahya B, Hevan Al-Atroushy A, et al. It is possible to create a vascular access team in a middle resource country? Experience of Hevi Paediatric Teaching Hospital at DUHOK - IRAQ. J Vasc Access. 2021;11297298211055402doi: 10.1177/11297298211055402.
Federica, B., Nizar Yahya, B., Hevan Al-Atroushy, A., Wahida Ibraheem, A., Bayar Saleem, H., Bijeen Fareq, J., Sholker Khalid, M., Shaima Shimo, J., Nora Suleeman, S., Saad Zebari, M., & Stefano, M. (2021). It is possible to create a vascular access team in a middle resource country? Experience of Hevi Paediatric Teaching Hospital at DUHOK - IRAQ. The journal of vascular access, 11297298211055402. https://doi.org/10.1177/11297298211055402
Federica, Buzzi, et al. "It is possible to create a vascular access team in a middle resource country? Experience of Hevi Paediatric Teaching Hospital at DUHOK - IRAQ." The journal of vascular access vol. (2021): 11297298211055402. doi: https://doi.org/10.1177/11297298211055402
Federica B, Nizar Yahya B, Hevan Al-Atroushy A, Wahida Ibraheem A, Bayar Saleem H, Bijeen Fareq J, Sholker Khalid M, Shaima Shimo J, Nora Suleeman S, Saad Zebari M, Stefano M. It is possible to create a vascular access team in a middle resource country? Experience of Hevi Paediatric Teaching Hospital at DUHOK - IRAQ. J Vasc Access. 2021 Dec 13;11297298211055402. doi: 10.1177/11297298211055402. Epub 2021 Dec 13. PMID: 34903090.
Copy Download .nbib Format: NLM
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease.

Frontiers in pharmacology

Caruso G, Grasso M, Fidilio A, Torrisi SA, Musso N, Geraci F, Tropea MR, Privitera A, Tascedda F, Puzzo D, Salomone S, Drago F, Leggio GM, Caraci F.
PMID: 35002742
Front Pharmacol. 2021 Dec 24;12:809541. doi: 10.3389/fphar.2021.809541. eCollection 2021.

Depression is a risk factor for the development of Alzheimer's disease (AD). A neurobiological and clinical continuum exists between AD and depression, with neuroinflammation and oxidative stress being involved in both diseases. Second-generation antidepressants, in particular selective serotonin reuptake...

Cite
Caruso G, Grasso M, Fidilio A, et al. Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease. Front Pharmacol. 2021;12:809541doi: 10.3389/fphar.2021.809541.
Caruso, G., Grasso, M., Fidilio, A., Torrisi, S. A., Musso, N., Geraci, F., Tropea, M. R., Privitera, A., Tascedda, F., Puzzo, D., Salomone, S., Drago, F., Leggio, G. M., & Caraci, F. (2021). Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease. Frontiers in pharmacology, 12809541. https://doi.org/10.3389/fphar.2021.809541
Caruso, Giuseppe, et al. "Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease." Frontiers in pharmacology vol. 12 (2021): 809541. doi: https://doi.org/10.3389/fphar.2021.809541
Caruso G, Grasso M, Fidilio A, Torrisi SA, Musso N, Geraci F, Tropea MR, Privitera A, Tascedda F, Puzzo D, Salomone S, Drago F, Leggio GM, Caraci F. Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease. Front Pharmacol. 2021 Dec 24;12:809541. doi: 10.3389/fphar.2021.809541. eCollection 2021. PMID: 35002742; PMCID: PMC8740153.
Copy Download .nbib Format: NLM
Obturator dislocation of the hip associated with ipsilateral quadrilateral plate fracture: A rare case report.

Trauma case reports

Ceri L, Zanna L, Buzzi R, De Biase P.
PMID: 33763515
Trauma Case Rep. 2021 Mar 11;32:100451. doi: 10.1016/j.tcr.2021.100451. eCollection 2021 Apr.

Traumatic hip dislocations typically result of high-energy trauma and frequently involve young patients. The obturator dislocation is not a common condition and rarely combined with acetabular fracture. We report a rare case of a 48-year-old male patient with a...

Cite
Ceri L, Zanna L, Buzzi R, et al. Obturator dislocation of the hip associated with ipsilateral quadrilateral plate fracture: A rare case report. Trauma Case Rep. 2021;32:100451doi: 10.1016/j.tcr.2021.100451.
Ceri, L., Zanna, L., Buzzi, R., & De Biase, P. (2021). Obturator dislocation of the hip associated with ipsilateral quadrilateral plate fracture: A rare case report. Trauma case reports, 32100451. https://doi.org/10.1016/j.tcr.2021.100451
Ceri, Lorenzo, et al. "Obturator dislocation of the hip associated with ipsilateral quadrilateral plate fracture: A rare case report." Trauma case reports vol. 32 (2021): 100451. doi: https://doi.org/10.1016/j.tcr.2021.100451
Ceri L, Zanna L, Buzzi R, De Biase P. Obturator dislocation of the hip associated with ipsilateral quadrilateral plate fracture: A rare case report. Trauma Case Rep. 2021 Mar 11;32:100451. doi: 10.1016/j.tcr.2021.100451. eCollection 2021 Apr. PMID: 33763515; PMCID: PMC7974022.
Copy Download .nbib Format: NLM
Reduced thrombogenicity of surface-treated Nitinol implants steered by altered protein adsorption.

Acta biomaterialia

Gegenschatz-Schmid K, Buzzi S, Grossmann J, Roschitzki B, Urbanet R, Heuberger R, Glück D, Zucker A, Ehrbar M.
PMID: 34673227
Acta Biomater. 2022 Jan 01;137:331-345. doi: 10.1016/j.actbio.2021.10.022. Epub 2021 Oct 19.

Blood-contacting medical implants made of Nitinol and other titanium alloys, such as neurovascular flow diverters and peripheral stents, have the disadvantage of being highly thrombogenic. This makes the use of systemic (dual) anti-platelet/anticoagulant therapies inevitable with related risks of...

Cite
Gegenschatz-Schmid K, Buzzi S, Grossmann J, et al. Reduced thrombogenicity of surface-treated Nitinol implants steered by altered protein adsorption. Acta Biomater. 2021;137:331-345doi: 10.1016/j.actbio.2021.10.022.
Gegenschatz-Schmid, K., Buzzi, S., Grossmann, J., Roschitzki, B., Urbanet, R., Heuberger, R., Glück, D., Zucker, A., & Ehrbar, M. (2022). Reduced thrombogenicity of surface-treated Nitinol implants steered by altered protein adsorption. Acta biomaterialia, 137331-345. https://doi.org/10.1016/j.actbio.2021.10.022
Gegenschatz-Schmid, Katharina, et al. "Reduced thrombogenicity of surface-treated Nitinol implants steered by altered protein adsorption." Acta biomaterialia vol. 137 (2022): 331-345. doi: https://doi.org/10.1016/j.actbio.2021.10.022
Gegenschatz-Schmid K, Buzzi S, Grossmann J, Roschitzki B, Urbanet R, Heuberger R, Glück D, Zucker A, Ehrbar M. Reduced thrombogenicity of surface-treated Nitinol implants steered by altered protein adsorption. Acta Biomater. 2022 Jan 01;137:331-345. doi: 10.1016/j.actbio.2021.10.022. Epub 2021 Oct 19. PMID: 34673227.
Copy Download .nbib Format: NLM
Career assessment and the Career Decision-Making Self-Efficacy Scale.

Journal of Career Assessment

Luzzo.
UIID-EM: 9
1996;4:413-428. doi: 10.1177/106907279600400405.

This article begins with a brief overview of the theories underlying the development of the Career Decision-Making Self-Efficacy Scale (CDMSE; K. M. Taylor and N. E. Betz, 1983), specifically A. Bandura's self-efficacy (e.g., 1977) theory and J. O. Crites's...

Cite
Luzzo. Career assessment and the Career Decision-Making Self-Efficacy Scale. 1996;4:413-428doi: 10.1177/106907279600400405.
Luzzo. (1996). Career assessment and the Career Decision-Making Self-Efficacy Scale. Journal of Career Assessment, 4413-428. https://doi.org/10.1177/106907279600400405
Luzzo, Darrell Anthony. "Career assessment and the Career Decision-Making Self-Efficacy Scale." Journal of Career Assessment vol. 4 (1996): 413-428. doi: https://doi.org/10.1177/106907279600400405
Luzzo. Career assessment and the Career Decision-Making Self-Efficacy Scale. 1996;4:413-428. doi: 10.1177/106907279600400405. UIID-EM: 9.
Copy Download .nbib Format: NLM
Reliability and validity testing of the Career Decision-Making Self-Efficacy Scale.

Measurement and Evaluation in Counseling and Development

Luzzo.
UIID-EM: 53
1993;26:137-142.

Evaluated the reliability and validity of the Career Decision-Making Self-Efficacy Scale using a sample of 233 undergraduates. Results support the reliability and validity of the scale. (PsycINFO Database Record (c) 2012 APA, all rights reserved)

Cite
Luzzo. Reliability and validity testing of the Career Decision-Making Self-Efficacy Scale. 1993;26:137-142
Luzzo. (1993). Reliability and validity testing of the Career Decision-Making Self-Efficacy Scale. Measurement and Evaluation in Counseling and Development, 26137-142.
Luzzo, Darrell A. "Reliability and validity testing of the Career Decision-Making Self-Efficacy Scale." Measurement and Evaluation in Counseling and Development vol. 26 (1993): 137-142.
Luzzo. Reliability and validity testing of the Career Decision-Making Self-Efficacy Scale. 1993;26:137-142. UIID-EM: 53.
Copy Download .nbib Format: NLM
Showing 1909 to 1919 of 1919 entries